Monday, June 15, 9:00 – 10:30 pm
Auditorium Lulli

Chairs: Markus Moehler (Germany) – Dave Wang 

1. Early-onset gastroesophageal cancer – a distinct entity? – Irit Ben-Aharon (Israel)
2. After neoadj therapy with (n)cCR, local endoscopic resections? – Pech Oliver 
3. Pro: First joice Chemo (instead of CROSS) in adenocarcinoma of esophagus. – Eduardo Terán
4. Contra: First joice CROSS (instead Chemo) in adenocarcinoma of esophagus. – Mike Gibson
5. De-escalation strategies in oesogastric adenocarcinomas: is the time right? – Christelle De la Fouchardière (France)
6. Young or old: Do we differentiate in intensity of multimodal care? TBD
7. MSI: how do we treat, w+w or operate? – Thierry André (France)
8. ASCO 2026: New important SOC-changing phase III trials? – Lucjan Wyrwicz
9. Multidisciplinary Tumor Board-Harmonizing other Local and Systemic Control in Gastric or Gastroesophageal Cancer. – Hanoch Kashtan
10. Decision making and translational research: Challenges and evidence in tumor conferences. – Tania Fleitas Kanonnikoff 
11. Sport program and Resilience: what helps in perioperative setting? – Katja Petrowski